MSACL Presenter Biography

Bruno Domon
Luxembourg Clinical Proteomics Center

Bruno Domon joined the Centre de Recherche Public Santé in Luxembourg to lead the new Clinical Proteomics Center, funded by the Fonds National de la Recherche through a PEARL grant. His main focus is the development of novel mass spectrometry-based proteomics methodologies, and its application to biomarker discovery and evaluation, and to proteomics in general. Previously, Bruno Domon was group leader and principal investigator at the Institute of Molecular Systems Biology at ETH Zurich heading the mass spectrometry laboratory and the biomarker program. As director at Celera Genomics in Rockville MD, USA he led the proteomics program on drug target discovery in oncology, which resulted in the identification of cell surface proteins for therapeutic development and diagnostics. Prior to that, he was associated director heading the mass spectrometry facility at Biogen in Cambridge MA, USA.